2024 Annual Report
Explore AdvaMed’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.
My Profile
Member Center
Policy
Top Priorities
On behalf of our members, AdvaMed works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
Your Featured Resources
AdvaMed 2025 State Policy Briefing: Data Privacy
Hear from AdvaMed’s data privacy expert, Terry Chang, on the critical exemptions we seek in comprehensive data privacy laws across the country.
AdvaMed 2025 State Policy Briefing: AI in Healthcare
AdvaMed’s digital health policy expert, Geeta Pamidimukkala, and payment and health care delivery policy expert, Kirsten Tullia, break down how artificial intelligence and machine learning (AI/ML) technologies are transforming patient…
AdvaMed Advancements: Q4 2024 Report
AdvaMed is proud to showcase the significant achievements we accomplished in Q4 of 2024.
AdvaMed Recommendations to CMS Regarding Sunshine Reporting Audits
AdvaMed, the world’s leading medtech trade association, communicated to Centers for Medicaid & Medicare Services (CMS) recommendations regarding administration of the Open Payments program.
Additional Resources
2024 Annual Report
Explore AdvaMed’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.
AdvaMed 2025 State Policy Briefing: Data Privacy
Hear from AdvaMed’s data privacy expert, Terry Chang, on the critical exemptions we seek in comprehensive data privacy laws across the country.
AdvaMed 2025 State Policy Briefing: AI in Healthcare
AdvaMed’s digital health policy expert, Geeta Pamidimukkala, and payment and health care delivery policy expert, Kirsten Tullia, break down how artificial intelligence and machine learning (AI/ML) technologies are transforming patient…
Discover More Resources
AdvaMed members have access to our full library of industry resources.
You are not logged in to the AdvaMed Hub.
Celebrating Medtech in Motion: 2024 Progress and Impact
We took time to reflect on another extraordinary year in the medtech industry and the tremendous strides we’ve made together. Our 2024 AdvaMed Annual Report highlights our key policy wins,…
AdvaMed Congratulates HHS Secretary Robert F. Kennedy, Jr.
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Robert F. Kennedy, Jr. to serve as Secretary of…
RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center
RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion® X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC)…
Medtech POV Podcast: Rep. Brad Wenstrup on COVID-19 Lessons, Common Sense in Health Care, and Treating Shooting Victim Scalise
On the Medtech POV podcast, AdvaMed President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring…
AdvaMed Imaging Celebrates Major Milestones in 2024, Lays Groundwork for 2025
Recap AdvaMed’s Medical Imaging Divisions achievements for members and the industry during its inaugural year with the medtech association.
AdvaMed Seeks Medical Technology Exemption from All Tariffs
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
AdvaMed Launches State-focused “Patients First” Agenda
Today, AdvaMed, the Medtech Association, released its “Patients First Agenda,” a series of state-level policies aimed at improving lives and patient outcomes through increasing access to medical technology, accurate diagnostic…
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the TriVerity™ Test System (TriVerity), a first-in-class molecular test for…
Medtech POV Podcast Guest, Jake Leach of Dexcom: Glucose Biosensing Provides Value for Patients
On the Medtech POV podcast , AdvaMed President and CEO Scott Whitaker sat down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the…
MedTechVets Appoints Michael Minogue as Next Chairman of Board of Directors
MedTechVets, a leading nonprofit organization dedicated to helping military veterans transition and find a career with purpose in the Medical Technology Industry through education, mentoring, and networking, is pleased to…
Membership Newsletter
We are pleased to provide AdvaMed members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.